- Home
- / FoRx Therapeutics
FoRx Therapeutics
Total Funding
$10.8 M
FoRx Therapeutics Summary
Company Summary
- Overview
- FoRx Therapeutics is a company that develops cancer drugs intended to focus on novel DNA Replication Stress pathways activated in cancer. The company focuses on drugging key molecular targets involved in DNA replication stress, as a new approach towards the development of targeted anticancer drugs.
- Type
- Private
- Status
- Active
- Founded
- 2019
- HQ
- Basel, CH | view all locations
- Website
- http://forxtherapeutics.com/
- Cybersecurity rating
Table of Contents
Key People
Colin Goddard, Executive Chairman of the Board
Tarig Bashir, CEO, Director
Therese Maria Liechtenstein, Director
